News articles about Danaher Corporation (NYSE:DHR) have trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Danaher Corporation earned a coverage optimism score of 0.20 on Accern’s scale. Accern also gave media headlines about the conglomerate an impact score of 45.7326390432247 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- Danaher Corporation Stocks Unloaded By Middleton Co MA (techkenyot.com)
- PICTET BANK & TRUST Ltd Decreases Stake in Danaher Corporation (NYSE:DHR) (iphonefresh.com)
- Akre Capital Management LLC Lowers Its Ownership in Danaher Corporation (DHR) (fishinghd.com)
- Akre Capital Management LLC Marginally Decreases Its Ownership in Danaher Corporation (DHR) Stock Last Quarter – Modern Readers (modernreaders.com)
- Danaher Corporation Receives “Buy” Recommendation from Jefferies Group – Insider Tradings (insidertradings.org)
DHR has been the topic of several research analyst reports. Janney Montgomery Scott cut Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Cowen and Company reissued an “outperform” rating and set a $90.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. Finally, William Blair reissued an “outperform” rating on shares of Danaher Corporation in a report on Sunday, April 23rd. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $91.76.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.90 earnings per share. Equities research analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of the company’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,623 shares of company stock valued at $3,206,426. Insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.